Extensive environmental contamination and prolonged severe acute respiratory coronavirus-2 (SARS CoV-2) viability in immunosuppressed recent heart transplant recipients with clinical and virologic benefit with remdesivir

Infect Control Hosp Epidemiol. 2022 Jun;43(6):817-819. doi: 10.1017/ice.2021.89. Epub 2021 Mar 12.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Alanine / analogs & derivatives
  • COVID-19 Drug Treatment*
  • Heart Transplantation*
  • Humans
  • Severe Acute Respiratory Syndrome*

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine